Drug profile · INN
avalglucosidase alfa-ngpt
NEXVIAZYME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
avalglucosidase alfa-ngpt (NEXVIAZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN avalglucosidase alfa-ngpt
Brand NEXVIAZYME
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is avalglucosidase alfa-ngpt?
avalglucosidase alfa-ngpt (NEXVIAZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for avalglucosidase alfa-ngpt?
NEXVIAZYME is a marketed brand name for avalglucosidase alfa-ngpt. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of avalglucosidase alfa-ngpt?
avalglucosidase alfa-ngpt has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.